J 2023

Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes

HÁJKOVÁ, Nikola, Michaela BÁRTŮ KENDALL, David CIBULA, Jana DROZENOVÁ, Pavel FABIAN et. al.

Basic information

Original name

Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes

Authors

HÁJKOVÁ, Nikola (203 Czech Republic), Michaela BÁRTŮ KENDALL (203 Czech Republic), David CIBULA (203 Czech Republic), Jana DROZENOVÁ (203 Czech Republic), Pavel FABIAN (203 Czech Republic), Oluwole FADARE, Filip FRÜHAUF (203 Czech Republic), Jitka HAUSNEROVÁ (203 Czech Republic, belonging to the institution), Jan HOJNÝ (203 Czech Republic), Eva KRKAVCOVÁ (203 Czech Republic), Jan LACO (203 Czech Republic), Sigurd F LAX, Radoslav MATĚJ (203 Czech Republic), Gábor MÉHES, Romana MICHÁLKOVÁ (203 Czech Republic), Kristýna NĚMEJCOVÁ (203 Czech Republic), Naveena SINGH, Simona STOLNICU (203 Czech Republic), Marián ŠVAJDLER (203 Czech Republic), Tomáš ZIMA (203 Czech Republic), Wilson Glenn MCCLUGGAGE, Ivana STRUŽINSKÁ (203 Czech Republic) and Pavel DUNDR (203 Czech Republic)

Edition

Translational research, NEW YORK, ELSEVIER SCIENCE INC, 2023, 1931-5244

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30109 Pathology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 7.800 in 2022

RIV identification code

RIV/00216224:14110/23:00131347

Organization unit

Faculty of Medicine

UT WoS

001067763800001

Keywords in English

non-endometrioid ovarian epithelial tumors; microsatellite instability

Tags

Tags

International impact, Reviewed
Změněno: 12/1/2024 13:39, Mgr. Tereza Miškechová

Abstract

V originále

Testing of microsatellite instability is not only used as a triage for possible Lynch syndrome, but also to predict immunotherapy treatment response. The aim of this study was to assess the frequency of mismatch repair deficiency (MMR-D)/microsatellite instability (MSI) in 400 cases of non-endometrioid ovarian tumors (high-grade serous, low-grade serous, mucinous and clear cell), to compare different methodological approaches of testing, and to assess the optimal approach for next generation sequencing (NGS) MSI testing. For all tumors, we evaluated immunohistochemical (IHC) expression of MMR proteins and assessed microsatellite markers by PCR-based method. Except for high-grade serous carcinoma, we correlated the findings of IHC and PCR with NGS-based MSI testing. We compared the results with somatic and germline mutation in MMR genes. Among the whole cohort, seven MMR-D cases, all clear cell carcinomas (CCC), were found. On PCR analysis, 6 cases were MSI-high and one was MSS. In all cases, mutation of an MMR gene was found; in 2 cases, the mutation was germline (Lynch syndrome). An additional 5 cases with a mutation in MMR gene(s) with MSS status and without MMR-D were identified. We further utilized sequence capture NGS for MSI testing. Employing 53 microsatellite loci provided high sensitivity and specificity. Our study shows that MSI occurs in 7% of CCC while it is rare or absent in other nonendometrioid ovarian neoplasms. Lynch syndrome was present in 2% of patients with CCC. However, some cases with MSH6 mutation can evade all testing methods, including IHC, PCR, and NGS-MSI.

Links

90233, large research infrastructures
Name: BBMRI.cz IV